Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC-atrial fibrillation project
机构：[1]Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China首都医科大学附属安贞医院[2]Division of Cardiology, University of North Carolina, Chapel Hill, NC, USA[3]Department of Cardiology, Peking University First Hospital, Beijing, China[4]Division of Cardiology, Geffen School of Medicine at University of California, Los Angeles, CA, USA[5]Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China[6]Department of International Science, American Heart Association, Basel, Switzerland[7]International Quality Improvement Department, American Heart Association, Dallas, TX, USA[8]Cardiovascular Research Institute and Department of Cardiology, General Hospital of Shenyang Military Region, Shenyang, Liaoning, China[9]Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing, China临床科室心脏内科中心首都医科大学附属安贞医院
第一作者机构：[1]Department of Epidemiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China
推荐引用方式(GB/T 7714)：
Yang Na,Liu Jing,Liu Jun,et al.Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC-atrial fibrillation project[J].JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY.2018,72(16):C137-C137.doi:10.1016/j.jacc.2018.08.643.
APA：
Yang, Na,Liu, Jing,Liu, Jun,Hao, Yongchen,Smith, Sidney C., Jr....&Zhao, Dong.(2018).Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC-atrial fibrillation project.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,72,(16)
MLA：
Yang, Na,et al."Prescription of dabigatran and rivaroxaban at discharge for atrial fibrillation patients with different classes of renal function: Findings from the CCC-atrial fibrillation project".JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 72..16(2018):C137-C137
医学